Few materials in medicine have a longer or better-documented track record than silver. Burn units have relied on it in one form or another since the 1960s, and it remains a fixture in wound-care formularies today. This article lays out what the actual research says about silver's antimicrobial behavior, how chitosan came to be paired with it, where the clinical evidence is strong versus thin, and how these materials show up in modern topical hygiene products such as chelated-silver and chitosan skin preparations — which are cosmetic hygiene products, not approved drugs, and are not a substitute for medical treatment of any wound or infection.

A Short History: Silver's Long Run in Burn Care

The modern era of silver in burn treatment traces to 1965, when Carl Moyer and colleagues at Washington University in St. Louis published work in the Archives of Surgery showing that 0.5% silver nitrate soaks, applied continuously to burn wounds, reduced infection-related complications compared to the antiseptics then in common use. The problem was that silver nitrate alone was messy, stained everything black, and could pull electrolytes out of the body through the wound. Three years later, Charles Fox Jr., working at Columbia University, combined silver with the antibiotic sulfadiazine to create silver sulfadiazine — the cream widely known by the brand name Silvadene. Fox's 1968 paper describing its activity against Pseudomonas in burn wounds effectively set the standard of care for burn units for the next several decades, and silver sulfadiazine remains on hospital formularies today.

Nanocrystalline silver dressings arrived in the 1990s, developed with research support from the University of Alberta, where Robert Burrell's laboratory characterized how very small silver particles release ions more steadily than bulk silver metal or silver salts. These dressings, applied as a sheet rather than a cream, became common in burn and plastic surgery units because they required less frequent dressing changes than silver sulfadiazine.

How Silver Works Against Microbes — and Where the Science Gets Nuanced

Silver's antimicrobial action does not come from the metal itself but from the silver ion, Ag⁺, released when silver metal, salts, or nanoparticles contact moisture. In laboratory studies, silver ions bind to sulfur-containing groups in bacterial proteins and enzymes, disrupt cell membranes, and interfere with DNA replication. This multi-target action is one reason bacteria develop resistance to silver far less readily than they do to many antibiotics — though it is not impossible. A 2003 review by Simon Silver in FEMS Microbiology Reviews documented a silver-resistance gene cluster, the sil operon, in some strains of Salmonella and E. coli, confirming that silver resistance exists in nature even if it remains uncommon.

It is important to be precise about what "kills bacteria in a dish" does and does not tell us. In vitro studies consistently show silver ions are effective against a broad range of bacteria, including Pseudomonas aeruginosa and Staphylococcus aureus, the organisms burn patients are most vulnerable to. But cell-culture studies from groups such as Amy Burd and colleagues, published in Wound Repair and Regeneration around 2007, also found that nanocrystalline silver at concentrations used clinically can be toxic to human keratinocytes and fibroblasts — the very skin cells needed to close a wound. That tension, antimicrobial benefit weighed against a cytotoxic cost to healing tissue, is the central scientific debate around silver in wound care, and it has never fully resolved.

Chitosan: A Second Material Drawn From the Created World

Chitosan is a polysaccharide derived from chitin, the structural material found in the shells of shrimp and crab and in the cell walls of many fungi. It is a striking example of how the created order provides useful materials in unexpected places — a byproduct of the seafood industry turned into a biomedical material. Chemically, chitosan carries a positive charge in mildly acidic conditions, which allows it to interact with the negatively charged surfaces of bacterial cell membranes and with red blood cells.

That red-blood-cell interaction is why chitosan's best-documented clinical use is not antimicrobial but hemostatic. The HemCon bandage, cleared by the FDA in 2003, uses a chitosan matrix to promote clotting and was adopted by the U.S. military for battlefield hemorrhage control after animal studies and battlefield case reports described faster bleeding control than standard gauze in severe wounds. Chitosan also forms a flexible, adherent film on skin, which is why it is used as a carrier and moisture-retentive base in various topical formulations, independent of any drug claim.

What the Human Trial Evidence Actually Shows

This is where honesty matters most. Despite silver's long history, the Cochrane Collaboration — an independent body that reviews randomized controlled trials — has repeatedly found the clinical evidence for silver dressings thinner than the widespread use of silver would suggest. A Cochrane review on silver dressings for wound healing, and a separate 2013 Cochrane review specifically on silver sulfadiazine for burns, both concluded that the quality of available trials was generally low to moderate, and that silver sulfadiazine did not clearly outperform other modern dressings on healing time; some trials suggested it may even delay healing compared to certain alternatives, consistent with the cytotoxicity findings noted above. This is a meaningful reason burn units have gradually diversified away from silver sulfadiazine as the sole standard, incorporating other dressing technologies alongside it.

None of this means silver is useless — it means the strongest evidence supports silver's antimicrobial activity against bacteria in laboratory and some animal models, while evidence that silver dressings improve human healing outcomes, as opposed to reducing bacterial counts, is weaker and inconsistent. Readers deserve that distinction rather than a flattened claim in either direction. Good stewardship of one's own health means understanding that difference and discussing it with a treating physician rather than assuming decades of use automatically settles the clinical question.

Chelated Silver, Chitosan, and Everyday Skin Hygiene

Outside the burn unit, silver and chitosan have found a place in everyday topical hygiene products, distinct from prescription burn dressings. In these formulations, silver is often "chelated" — bound to an organic molecule that regulates how the silver ion is held and released, rather than left as a free salt or bulk nanoparticle. Chelation chemistry is a well-established branch of materials science; it does not by itself confer any therapeutic claim, but it can change stability, texture, and how a compound behaves on the skin surface.

Products such as GermProof combine chelated silver with chitosan in a topical skin preparation intended for use as part of a personal hygiene routine — for example, applied to intact skin as one would use a hygiene wash or barrier product. It is important to be plain about what such a product is and is not: GermProof is not an FDA-approved drug, and it is not represented as treating, curing, or preventing any disease or infection. It should be understood as a hygiene product built from materials — chelated silver and chitosan — that have a long history of study in other contexts, used here for routine skin-care purposes rather than as a medical treatment. Anyone with an open wound, a burn, a chronic ulcer, or a diabetic foot concern should be evaluated and treated by a physician or wound-care specialist, not by any over-the-counter hygiene product.

Practical Hygiene Principles That Matter More Than Any Single Product

Whatever materials are involved, the evidence from burn and wound-care research points to a few practices that consistently matter more than the choice of any single topical agent:

Preparedness-minded households are right to want to understand these materials and keep sound hygiene supplies on hand. That is a reasonable and responsible instinct. It should sit alongside, not replace, a working relationship with a physician who can evaluate an actual wound or burn and advise on real treatment, including whether a prescription silver-based dressing is appropriate.

Key takeaway: Silver and chitosan are well-studied materials with a genuine, decades-long history in burn care, but the strongest evidence supports their antimicrobial and hemostatic properties in the lab and in specific medical dressings — not blanket healing claims — so any wound, burn, or infection still belongs in the hands of a physician, with hygiene products used for hygiene, not as a treatment.